Puma Biotechnology, Inc. (PBYI) vs Tectonic Therapeutic, Inc. (TECX)
Puma Biotechnology, Inc. and Tectonic Therapeutic, Inc. are both Biotechnology companies. Puma Biotechnology, Inc. and Tectonic Therapeutic, Inc. are of similar size ($506.9M and $471.5M). Tectonic Therapeutic, Inc. has negative trailing earnings, so its P/E is not meaningful; Puma Biotechnology, Inc. trades at 18.1×. Puma Biotechnology, Inc. has the higher net margin (11.6% vs 0.00%) and the higher return on invested capital (42.6% vs 0.00%). Across the 13 metrics below, Puma Biotechnology, Inc. leads on 10 and Tectonic Therapeutic, Inc. on 3.
Valuation
Profitability
| Metric | PBYI | TECX | Biotechnology median |
|---|---|---|---|
| Gross margin | 74.83% | 0.00% | 65.16% |
| Operating margin | 13.16% | 0.00% | 0.00% |
| Net margin | 11.55% | 0.00% | 0.00% |
| Free cash flow margin | 17.79% | 0.00% | 0.00% |
| Return on equity | 21.97% | (33.80%) | (57.72%) |
| Return on assets | 13.78% | (32.23%) | (49.22%) |
| Return on invested capital | 42.61% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack